Quipt Home Medical CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Quipt Home Medical Corp. announced the expiration of the HSR waiting period for its acquisition by 1567208 B.C. Ltd. for $3.65 per share in cash, moving the transaction closer to completion.
Quipt Home Medical Corp. announced a special shareholder meeting on March 3, 2026, to vote on a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.
Quipt Home Medical Corp. will be acquired by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share in an all-cash transaction.
DEFA14A: Quipt Home Medical Reaches Cooperation Agreement with Kanen Wealth Management, Averting Proxy Fight
Quipt Home Medical Corp. and Kanen Wealth Management have entered into a cooperation agreement, resolving a potential proxy battle and focusing on enhancing shareholder value.
Quipt Home Medical acknowledges notice from Kanen Wealth Management (KWM) regarding their intent to solicit proxies for alternative director candidates and reaffirms its commitment to shareholder value and corporate governance.
Quipt Home Medical is addressing a proxy solicitation from Philotimo Fund, which intends to nominate its own director candidates, potentially leading to additional costs and revised proxy materials.
Quipt Home Medical Corp. has scheduled its 2025 Annual Meeting for March 17, 2025, and is providing shareholders with details on how to vote on key proposals.
Quipt Home Medical Corp. will hold its annual general meeting on March 17, 2025, to elect directors and re-appoint auditors.
Quipt Home Medical Corp. will hold its annual general meeting on March 17, 2025, to discuss financial statements, elect directors, and appoint auditors.